Detalles de la búsqueda
1.
Spatial spread of COVID-19 during the early pandemic phase in Italy.
BMC Infect Dis
; 24(1): 450, 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38684947
2.
Socioeconomic Inequalities in SARS-CoV-2 Infection and COVID-19 Health Outcomes in Urban Italy During the COVID-19 Vaccine Rollout, January-November 2021.
J Urban Health
; 101(2): 289-299, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38498248
3.
Risk of breakthrough infection and hospitalisation after COVID-19 primary vaccination by HIV status in four Italian regions during 2021.
BMC Public Health
; 24(1): 1569, 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38862939
4.
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
Lancet
; 400(10346): 97-103, 2022 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35780801
5.
Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023.
Euro Surveill
; 28(32)2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37561053
6.
Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥â¯60 years, by time since infection, Italy, 12 September to 11 December 2022.
Euro Surveill
; 28(8)2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36820640
7.
Risk and protective factors for SARS-CoV-2 reinfections, surveillance data, Italy, August 2021 to March 2022.
Euro Surveill
; 27(20)2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35593164
8.
Estimating averted COVID-19 cases, hospitalisations, intensive care unit admissions and deaths by COVID-19 vaccination, Italy, January-September 2021.
Euro Surveill
; 26(47)2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34823637
9.
Fondaparinux Use in Patients With COVID-19: A Preliminary Multicenter Real-World Experience.
J Cardiovasc Pharmacol
; 76(4): 369-371, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33027192
10.
Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables.
BMC Genomics
; 19(1): 963, 2018 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30587120
11.
A statistical test for detecting parent-of-origin effects when parental information is missing.
Stat Appl Genet Mol Biol
; 16(4): 275-289, 2017 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-28862993
12.
Joint assessment of handedness and footedness through latent class factor analysis.
Laterality
; 23(6): 643-663, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29400133
13.
Growth curves of "normal" serum total IgE levels throughout childhood: A quantile analysis in a birth cohort.
Pediatr Allergy Immunol
; 28(6): 525-534, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28544337
14.
The impact of underreported infections on vaccine effectiveness estimates derived from retrospective cohort studies.
Int J Epidemiol
; 53(3)2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38847783
15.
Effectiveness against severe COVID-19 of a seasonal booster dose of bivalent (original/Omicron BA.4-5) mRNA vaccines in persons aged ≥60 years: Estimates over calendar time and by time since administration during prevalent circulation of different Omicron subvariants, Italy, 2022-2023.
Vaccine
; 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38834428
16.
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.
Influenza Other Respir Viruses
; 18(4): e13292, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38654485
17.
Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 - February 2022).
Int J Infect Dis
; 129: 135-141, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36708869
18.
Estimated Effectiveness of a Primary Cycle of Protein Recombinant Vaccine NVX-CoV2373 Against COVID-19.
JAMA Netw Open
; 6(10): e2336854, 2023 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37792377
19.
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study.
Lancet Infect Dis
; 23(12): 1349-1359, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37478877
20.
Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study.
Vaccine
; 41(1): 76-84, 2023 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36400660